Search
Home
Products
Rasagiline mesylate
Rasagiline mesylate WeChat WhatsApp
Product Name Rasagiline mesylate
Price: Inquiry
Catalog No.: CN02014
CAS No.: 161735-79-1
Molecular Formula: C13H17NO3S
Molecular Weight: 267.34 g/mol
Purity: >=98%
Type of Compound: Alkaloids
Physical Desc.: Powder
Source:
Solvent: DMSO, Pyridine, Methanol, Ethanol, etc.
SMILES: CS(=O)(=O)O.C#CCN[C@@H]1CCc2c1cccc2
Contact us
First Name:
Last Name:
E-mail:
Question:
Description Rasagiline Mesylate is a new MAO-B inhibitor for the treatment of idiopathic Parkinson's disease. Target: Monoamine Oxidase (MAO)-BRasagiline (N-propargyl-1-(R)-aminoindan) is a novel, highly potent irreversible monoamine oxidase (MAO)-B inhibitor, anti-Parkinsonian drug. Rasagiline is effective as monotherapy or adjunct to L-Dopa for patients with early and late Parkinson's disease (PD) [1]. Rasagiline inhibits MAO-B more potently than selegiline and has the advantage of once-daily dosing. In several large, randomized, placebo-controlled trials, rasagiline has demonstrated efficacy as monotherapy in early PD and as adjunctive therapy in advanced PD. In addition, rasagiline has been shown to have neuroprotective effects in in vitro and in vivo studies. The recently completed delayed-start ADAGIO (Attenuation of Disease Progression with Azilect Given Once-daily) trial suggests a potential disease-modifying effect for rasagiline 1 mg/day, though the clinical import of this finding has yet to be established [2]. Rasagiline has been found to be well tolerated and effective in the treatment of early PD and as adjunctive treatment in motor fluctuations. Whether rasagiline is associated with clinically significant neuroprotection (ie, disease modification) in PD is the subject of ongoing clinical trials [3].
Density1.05 g/cm3
Boiling Point305.5ºC at 760 mmHg
Flash Point146.8ºC
Exact Mass267.092926
PSA74.78000
LogP2.87240
Vapour Pressure0.000816mmHg at 25°C
Storage condition-20°C Freezer